Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer

ConclusionsOverall, our proteomic data presented precise quantification of potential signatures, signaling pathways, regulatory networks, and characteristic differences in each clinicopathological subgroup. The proteome provides complementary information for TNBC accurate subtype classification and therapeutic targets research.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research